MDSCs also enrich breast cancer cells with stem-like properties by activating IL-6/STAT3 and NO/NOTCH signaling pathways with NO, leading to suppression of T cell activation (Peng et al., 2016). This evidence concerns the gene STAT3 and breast cancer.